DexCom, Inc. (NASDAQ:DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today announced the launch of Dexcom Academy, a new personalised learning ...
DexCom has been in for a rough ride this year. The medical technology company is grappling with concerns over its slowing growth and allegations of faulty blood glucose monitors.
Senate Republicans don’t see a bipartisan deal to extend enhanced health insurance premium subsidies coming together before the Christmas deadline, given the complexity of the issue and a growing ...
A new type of sensor that levitates dozens of glass microparticles could revolutionize the accuracy and efficiency of sensing, laying the foundation for better autonomous vehicles, navigation and even ...
The Insulet Omnipod 5 pump and Dexcom G7 15 Day CGM. [Images courtesy of the companies] Insulet (Nasdaq:PODD) today announced immediate compatibility between its Omnipod 5 system and the Dexcom ...
The extension of the extra financial help to buy Affordable Care Act health insurance is still up in the air. Republicans have politics and policy to weigh. It's open enrollment time for people who ...
LOS ANGELES, Nov. 28, 2025 (GLOBE NEWSWIRE) -- The DJS Law Group reminds investors of a class action lawsuit against DexCom, Inc. (“DexCom” or “the Company”) (NASDAQ: DXCM) for violations of §§10(b) ...
He said, though, he'd "rather not" and again pitched paying people directly. President Donald Trump now says extending Affordable Care Act subsidies "may be necessary" as the enrollment deadline looms ...
Incorrect low glucose readings from some Abbott continuous glucose monitoring (CGM) sensors have been potentially linked to 736 severe adverse events and seven deaths globally. Abbott reported this ...
Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. President Donald Trump talks after meeting with ...
White House may extend ACA (Obamacare) subsidies for two years Trump faces political balancing act on rising premiums Insurer shares jump on extension reports Nov 24 (Reuters) - The White House is ...
Abbott issued a medical device correction for some of its glucose sensors after internal testing found that some sensors may provide false low glucose readings. Hundreds of adverse events and seven ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback